Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety and the Efficacy of Tianshu Capsule Treating Migraine in a Randomized, Placebo-Controlled, Double-blind, Multicenter Study.

NCT02035111 is registered in ClinicalTrials.gov with Jiangsu Kanion Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT02035111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02035111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety and the Efficacy of Tianshu Capsule Treating Migraine in a Randomized, Placebo-Controlled, Double-blind, Multicenter Study.
Lead sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
November 30, 2015
Enrollment
947 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

migraine